Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C095105 |
bexarotene |
bexarotene results in increased expression of GLRA3 mRNA | increases expression | 16648578
|
D004958 |
Estradiol |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GLRA3 mRNA | affects cotreatment|decreases expression | 19619570
|
D004958 |
Estradiol |
Estradiol results in increased expression of GLRA3 mRNA | increases expression | 19619570
|
D008628 |
Mercury |
Mercury results in increased expression of GLRA3 mRNA | increases expression | 16823088
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GLRA3 mRNA | affects binding|increases activity|increases expression | 19710929
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of GLRA3 mRNA | increases expression | 17879257
|
D013749 |
Tetrachlorodibenzodioxin |
[Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GLRA3 mRNA | affects cotreatment|decreases expression | 19619570
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of GLRA3 mRNA | decreases expression | 19619570
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.31 | 14514962 15322242 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.47 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.16 | 11473722 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.49 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.49 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.22 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.42 | 16712894 17306315 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.25 | 11748828 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.76 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
5.29 | 16634805 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.87 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.87 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.31 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.95 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
bexarotene |
1.92 | 16818667 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.92 | 12948864 14630087 17289903 17018787 16675129 19861407 18497071 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.92 | 20435547 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.93 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.05 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.16 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.16 | 16507464 17306315 15276417 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
bexarotene |
3.31 | 16247446 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
2.45 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.52 | 16120746 18850075 18670907 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
3.54 | 10334427 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.44 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
7.44 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.45 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.05 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.21 | 15668235 8697196 16354765 15340226 12621046 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.34 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 10048152 20055451 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
4.20 | 16823706 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.55 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.70 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
1.60 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.99 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.42 | 18230668 15322242 16714409 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
3.17 | 11473722 18566989 19148513 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.33 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.24 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
3.09 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.87 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.36 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.14 | 16452187 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.12 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.47 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.71 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.66 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.69 | 16221962 18467677 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.69 | 15340226 12621046 16120746 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.55 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.43 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.27 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.57 | 8697196 16354765 15340226 18606429 16959395 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.49 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
2.00 | 18670907 18850075 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.19 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.99 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.84 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.84 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.66 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
11.19 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
11.19 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
11.19 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.24 | 15610895 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.54 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.54 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.54 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.94 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
7.94 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.94 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.28 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.37 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
bexarotene |
3.65 | 17849452 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.65 | 17077188 16712894 15276417 17306315 19931552 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.65 | 19555203 11884234 |
MESH:D016410 |
Lymphoma, T-Cell, Cutaneous |
|
bexarotene |
5.56 | 11161223 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
bexarotene |
6.89 | 15591091 19196723 19196722 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.89 | 16891317 11807958 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
5.00 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.06 | 19082730 16487513 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.92 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.25 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.27 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
9.06 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
9.06 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.40 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.40 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.08 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
bexarotene |
5.30 | 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.19 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.77 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.77 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.33 | 12854658 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.87 | 20558911 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
5.11 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.11 | 17306315 15276417 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.77 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.94 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.65 | 11896295 11118676 11222880 11399792 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.21 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.16 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.16 | 16039940 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.52 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.22 | 18990726 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
6.02 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
6.02 | 16192470 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.04 | 12854658 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.42 | 12697716 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.21 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.60 | 17306315 11723127 16712894 16452187 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
4.07 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.89 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.12 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.77 | 15886252 |